Clinical and experimental study on human neuronal circuitry and cellular heterogeneity impacted by early Alzheimer's disease -related pathology in iNPH patients (CLEAR)

Acronym

CLEAR

Description of the granted funding

This study aims to elucidate the cellular heterogenicity and neuronal network functions impacted by the early AD pathology in humans. We take advantage of the brain biopsies obtained during shunt surgeries of idiopathic normal pressure hydrocephalus patients from which a subpopulation of patients show early AD pathology including beta-amyloid deposits and tau as well as their extensive clinical history. We combine single cell sequencing with spatial mapping and electrophysiological recordings to reveal how early AD pathology promotes cellular dysfunctions in humans. This will pinpoint novel molecular targets for further validation and possibly new biomarkers.
Show more

Starting year

2021

End year

2025

Granted funding


Tarja Malm Orcid -palvelun logo
399 348 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Eastern Finland (339767)
300 000 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

339763

Fields of science

Neurosciences

Research fields

Neurotiede

Identified topics

brain, neuroscience